Archives
-
Glabridin-Gold(I) Complex Targets TrxR/MAPK to Boost Tumor I
2026-05-21
This article examines the development of a glabridin-gold(I) complex as a dual-action immunomodulatory agent, highlighting its targeted effects on thioredoxin reductase (TrxR) and MAPK pathways to enhance antitumor immunity. The findings signal new directions for overcoming the immunosuppressive tumor microenvironment in cancer therapy.
-
TBK1 Inhibition Reduces Microglia Pyroptosis in Diabetic Neu
2026-05-19
The reference study demonstrates that targeting TANK-binding kinase 1 (TBK1) alleviates painful diabetic neuropathy in mice by suppressing microglial pyroptosis. This mechanistic insight advances understanding of neuroinflammatory pathways in diabetes and points toward TBK1 inhibition as a novel therapeutic strategy.
-
PDGF-BB, Murine Recombinant Protein: Mitogen Action & Assay
2026-05-18
Murine recombinant PDGF-BB is a non-glycosylated, E. coli-expressed growth factor with potent mitogen activity. It specifically activates PDGFR-α/β, driving cell proliferation in vascular and connective tissues. APExBIO's PDGF-BB (SKU P1048) offers validated purity and reproducible assay performance.
-
Multimodal iPSC Platform Advances Cystic Fibrosis Drug Testi
2026-05-16
This study introduces a multimodal platform using iPSC-derived airway epithelial cells to model cystic fibrosis (CF) and test CFTR modulator efficacy. By enabling genotype-specific functional assays, the approach accelerates discovery and evaluation of precision therapies for both common and rare CFTR variants.
-
2,2,2-Trichloroethanol in Quantitative Protein Maturation St
2026-05-13
Explore the advanced use of 2,2,2-Trichloroethanol as a small molecule biochemical in protein analysis and neurobiological research. This article uniquely bridges its role in functional imaging, protein maturation assays, and translational neuroscience, offering insight beyond standard reagent guides.
-
Luminescent ATP Detection Assay Kit: Precision in GBM Metabo
2026-05-13
Harness the Luminescent ATP Detection Assay Kit to achieve ultrasensitive, reproducible ATP quantification in cellular and tissue models. This workflow-driven guide translates recent advances in glioblastoma metabolism research into actionable protocols, troubleshooting, and comparative insights.
-
Prestained Protein Marker: Triple Color Workflow Precision
2026-05-12
Unlock vivid, reproducible protein separation and transfer verification with the Prestained Protein Marker (Triple color, EDTA free, 10-250 kDa) from APExBIO. Its tri-color bands, EDTA-free compatibility, and ready-to-use formulation streamline SDS-PAGE, Western blotting, and advanced imaging workflows—empowering researchers to achieve robust, publication-ready data.
-
CCCP and Mitochondrial Dysfunction: From Uncoupling to Bioma
2026-05-08
Explore how CCCP (carbonyl cyanide m-chlorophenyl hydrazine) advances mitochondrial research—revealing unique insights into energy metabolism, assay design, and emerging biomarker applications. This in-depth analysis connects CCCP's mechanistic roles with next-generation diagnostic strategies.
-
Olaparib (AZD2281): Nanotechnology and Precision Delivery in
2026-05-06
Explore how Olaparib (AZD2281) enables next-generation cancer research through advanced delivery systems and mechanistic insight. This article uniquely details nanotechnology innovations and practical protocol strategies for DNA damage response and BRCA-associated cancer models.
-
InstaBlue Protein Stain Solution: Rapid Coomassie Gel Staini
2026-05-05
InstaBlue Protein Stain Solution streamlines protein visualization in polyacrylamide gels by providing a rapid, sensitive, and non-toxic alternative to conventional Coomassie stains. Use it where fast turnaround, mass spectrometry compatibility, and minimal background are required. It is not intended for workflows needing methanol/acetic acid fixation or for non-gel-based applications.
-
GPR107 Deficiency Drives Diabetic Nephropathy via AT1R/Ca2+
2026-05-04
Xu et al. reveal that loss of G protein-coupled receptor 107 (GPR107) accelerates diabetic nephropathy by disrupting collagen IV turnover in podocytes. Mechanistically, GPR107 deficiency impairs endocytosis of AT1R, intensifying calcium-mediated signaling and extracellular matrix accumulation, highlighting a novel therapeutic target for diabetic kidney disease.
-
ALDOB K87 Lactylation Orchestrates Mitochondrial Fission in
2026-05-03
This study reveals that ALDOB K87 lactylation is a central driver of mitochondrial fission and metabolic reprogramming in pulmonary hypertension (PH). By identifying a lactate–ALDOB–DRP1 signaling axis, the research provides new mechanistic insight into smooth muscle cell proliferation and vascular remodeling, with implications for future PH intervention strategies.
-
tiRNA: Aptamer-Mediated Translation Inhibition for Precise G
2026-05-02
The tiRNA platform introduces an aptamer-based, reversible gene silencing mechanism that blocks mRNA translation without RNA degradation. This approach offers enhanced precision and controllability for applications in gene therapy and disease models involving protein overexpression.
-
hiPSC-Derived Hepatobiliary Organoids: A Functional In Vitro
2026-05-01
This study establishes a robust method for generating hepatobiliary organoids from human induced pluripotent stem cells (hiPSCs) without exogenous cells or genetic manipulation. The resulting 3D organoids demonstrate functional hepatic and biliary attributes and offer a promising platform for liver development research and translational applications.
-
Diuron (3-(3,4-dichlorophenyl)-1,1-dimethylurea): Mechanisti
2026-04-30
Explore the mechanistic toxicology of Diuron (3-(3,4-dichlorophenyl)-1,1-dimethylurea) with new insights into acute renal injury and robust parameters for research assay design. This article delivers a distinct, evidence-based perspective for advanced plant and toxicology workflows.
411 records 9/28 page Previous Next First page 上5页 678910 下5页 Last page